At meeting held on 30 January 2019
The Board of Ajanta Pharma at its meeting held on 30 January 2019 has approved the proposal to buyback of not exceeding 7,69,230 equity shares (representing 0.87% of the total number of equity shares in the paid-up share capital of the Company) at a price of Rs. 1,300 per equity share (the "Buy Back Offer Price") payable in cash for an aggregate consideration not exceeding Rs. 100 crore (the "Buyback Offer Size") being 5.22% of the aggregate of the fully paid up equity share capital and free reserves as per the audited standalone financial statements and 4.96% and audited consolidated financial statements of the Company for the financial year ended 31 March 2018 (the last audited financial statements available as on the date of Board meeting recommending the proposal of the Buyback).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app